Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-11-27

Clinical Trial Update: Blue Light Photobiomodulation Therapy on Neuroischemic Patients [NA]

View source ↗

Summary

A clinical trial evaluating blue light photobiomodulation therapy for neuroischemic diabetic foot ulcers has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Emoled | Conditions: Diabetic Foot Ulcer | NA | Status: TERMINATED